|
Charles J. Casamento has served as a director of the Company since September 2002. Mr. Casamento is president and CEO of Osteologix Inc. a public biopharmaceutical company developing products for treating osteoporosis. From 1999 through August 2004 he served as chairman of the board president and CEO of Questcor Pharmaceuticals Inc. Mr. Casamento formerly served as RiboGene Inc.’s president CEO and chairman of the board from 1993 through 1999 until it merged with Cypros to form Questcor. He was co-founder president and CEO of Interneuron Pharmaceuticals Inc. a biopharmaceutical company from 1989 until 1993. Mr. Casamento has also held senior management positions at Genzyme Corporation where he was senior vice president pharmaceuticals and biochemicals; American Hospital Supply where he was vice president of business development and strategic planning for the Critical Care Division; Johnson & Johnson Hoffmann-LaRoche Inc. and Sandoz Inc. Mr. Casamento is also a director of CORTEX Pharmaceuticals a biopharmaceutical company. He holds a bachelor's degree in Pharmacy from Fordham University and an M.B.A. from Iona College and is a licensed pharmacist in the states of New York and New Jersey. | 